Iterum Therapeutics plc (ITRMF) Total Liabilities (2017 - 2025)

Iterum Therapeutics has reported Total Liabilities for 9 years, with the latest figure at $39.9 million in Q3 2025.

• On a quarterly basis, Total Liabilities rose 45.4% year-over-year to $39.9 million in Q3 2025; TTM through Sep 2025 was $39.9 million, a 45.4% increase from a year earlier, with the FY2024 full-year figure at $48.7 million, up 49.03% from the prior year.
• Total Liabilities was $39.9 million for Q3 2025 at Iterum Therapeutics, up from $37.9 million in the prior quarter.
• The five-year high for Total Liabilities was $83.6 million in Q1 2021, with the low at $25.1 million in Q2 2024.
• Average Total Liabilities over 5 years is $40.4 million, with a median of $38.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities tumbled 57.65% in 2022, then soared 51.08% in 2025.
• Over 5 years, Total Liabilities stood at $41.3 million in 2021, then dropped by 5.91% to $38.8 million in 2022, then dropped by 15.89% to $32.7 million in 2023, then surged by 49.03% to $48.7 million in 2024, then slipped by 18.06% to $39.9 million in 2025.
• The last three Total Liabilities figures came in at $39.9 million (Q3 2025), $37.9 million (Q2 2025), and $35.5 million (Q1 2025), per Business Quant data.